SMITH ASSET MANAGEMENT GROUP LP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 75 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 3.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$2,0000.0%1800.0%0.00%
Q1 2021$2,000
-95.8%
180
-96.7%
0.00%
-100.0%
Q4 2020$48,000
-22.6%
5,3800.0%0.00%0.0%
Q3 2020$62,000
-92.9%
5,380
-95.8%
0.00%
-88.5%
Q4 2015$870,000
+0.3%
129,420
-13.7%
0.03%
-21.2%
Q3 2015$867,000
-29.2%
149,930
-0.0%
0.03%
-19.5%
Q2 2015$1,224,000
+2.1%
149,960
+2.0%
0.04%
+2.5%
Q1 2015$1,199,000
+60.1%
146,969
+80.1%
0.04%
+53.8%
Q4 2014$749,000
-15.4%
81,590
-9.1%
0.03%
-21.2%
Q3 2014$885,000
-9.1%
89,800
-0.3%
0.03%
-8.3%
Q2 2014$974,00090,1100.04%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Sante Capital Fund, LP 115,637$1,072,0000.44%
Defender Capital, LLC. 135,466$1,255,0000.42%
Green Alpha Advisors, LLC 62,566$580,0000.40%
Harvest Investment Services, LLC 51,239$474,0000.20%
SEVEN EIGHT CAPITAL, LP 118,270$1,096,0000.15%
Cedar Brook Financial Partners, LLC 54,500$505,0000.15%
WASATCH ADVISORS LP 3,576,706$33,156,0000.14%
Banco BTG Pactual S.A. 20,000$185,0000.12%
Keystone Financial Group 60,712$563,0000.10%
Virtus ETF Advisers LLC 25,105$233,0000.10%
View complete list of INOVIO PHARMACEUTICALS INC shareholders